Gilead Sciences GILD Balance Sheet (2009-2026)

NASDAQ GILD
$150.92 -0.36 (-0.24%)
As of: Sep 30, 2026 · 12:07 PM EDT
Reported Financials

Gilead Sciences Quarterly Balance Sheet

Periods 70 quarters
Latest Jun 2026

Gilead Sciences reported total assets of $49.36B and total liabilities of $37.53B for the quarter ended Jun 2026, down 11.4% year over year. This balance sheet covers 70 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
4.36B5.34B4.30B4.74B4.70B5.41B4.94B5.70B5.71B6.08B4.72B2.77B5.04B9.99B7.93B5.14B7.33B7.56B7.63B3.18B
Short-term InvestmentsInvestments (Current)
1.38B1.18B1.03B0.92B0.96B0.97B0.94B0.96B1.16B1.18B0.07B0.02B0.07B0.01B
Cash & Current Investments
5.74B6.52B5.33B5.66B5.66B6.38B5.87B6.67B6.86B7.26B4.72B2.77B5.04B9.99B7.93B5.21B7.35B7.63B7.64B3.18B
Receivables - NetNet Receivables
4.57B4.49B3.79B4.12B4.35B4.78B4.16B4.23B4.79B4.66B4.67B4.66B4.59B4.42B4.39B4.78B5.09B4.91B4.74B5.05B
Receivables
4.57B4.49B3.79B4.12B4.35B4.78B4.16B4.23B4.79B4.66B4.67B4.66B4.59B4.42B4.39B4.78B5.09B4.91B4.74B5.05B
Raw Materials
Work In Process
Finished Goods
Inventory
1.68B1.62B1.48B1.49B1.46B1.51B1.58B1.63B1.66B1.79B1.85B2.03B1.87B1.71B1.76B1.82B1.78B1.77B1.91B1.95B
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
2.01B2.14B2.04B1.90B2.08B1.77B1.85B1.76B2.66B2.37B2.80B2.86B3.29B3.05B2.83B2.90B3.65B4.02B4.34B3.76B
Current Assets
13.99B14.77B12.63B13.18B13.55B14.44B13.46B14.29B15.98B16.09B14.04B12.32B14.78B19.17B16.90B14.72B17.87B18.34B18.64B13.95B
Non-Current Assets
Buildings
3.79B4.39B4.33B4.54B4.62B
Construction in Progress
1.06B0.72B0.66B0.50B0.74B
Land & Improvements
Property, Plant & Equipment (Net)PP&E (Net)
5.04B5.12B5.25B5.30B5.35B5.47B5.48B5.54B5.57B5.32B5.32B5.35B5.39B5.41B5.42B5.46B5.50B5.61B5.64B5.83B
Long-Term Investments
1.10B1.31B1.43B1.34B1.28B1.25B1.33B1.33B1.16B1.16B1.91B2.00B2.97B0.98B
Goodwill
8.33B8.33B8.31B8.31B8.31B8.31B8.31B8.31B8.31B8.31B8.31B8.31B8.31B8.31B8.31B8.31B8.31B8.31B8.31B8.31B
Intangibles
33.90B33.45B30.33B29.89B29.44B28.89B28.35B27.75B27.15B26.45B23.43B22.83B20.55B19.95B19.36B18.57B17.97B16.98B16.38B14.03B
Goodwill & Intangibles
42.23B41.79B38.65B38.20B37.75B37.21B36.66B36.06B35.47B34.77B31.74B31.15B28.86B28.26B27.67B26.88B26.28B25.29B24.70B22.35B
Long-Term Deferred Tax
2.38B2.57B2.72B2.00B1.96B1.77B2.49B
Other Non-Current Assets
4.74B4.96B5.13B4.86B4.62B4.80B4.95B5.11B4.20B4.79B5.19B4.77B5.49B3.77B3.87B4.03B4.87B4.84B4.55B4.75B
Non-Current Assets
53.11B53.18B50.45B49.70B49.00B48.73B48.42B48.05B46.39B46.04B42.25B41.26B39.75B39.82B39.53B41.00B40.66B40.68B37.64B35.42B
Assets
67.10B67.95B63.08B62.87B62.56B63.17B61.88B62.34B62.37B62.12B56.29B53.58B54.52B58.99B56.43B55.72B58.53B59.02B56.28B49.36B
Liabilities
Current Liabilities
Accounts Payables
0.58B0.70B0.58B0.56B0.61B0.91B0.63B0.62B0.59B0.55B0.62B0.54B0.90B0.83B0.74B0.58B0.81B0.71B0.65B0.67B
Payables
0.58B0.70B0.58B0.56B0.61B0.91B0.63B0.62B0.59B0.55B0.62B0.54B0.90B0.83B0.74B0.58B0.81B0.71B0.65B0.67B
Accumulated Expenses
3.78B6.14B3.50B4.12B3.87B
Other Accumulated Expenses
6.14B4.58B4.14B5.81B5.85B5.13B4.46B4.51B4.90B5.46B4.62B3.59B3.75B3.95B3.40B3.70B
Short term Debt
2.51B1.52B1.02B1.02B2.27B2.27B2.28B4.04B1.79B1.80B3.67B1.81B1.81B1.81B2.81B2.81B2.81B2.81B1.31B2.41B
Current Taxes
Current Deferred Revenue
Total Current Liabilities
10.24B11.61B8.56B9.22B10.42B11.24B10.53B13.96B11.95B11.28B13.02B10.78B11.72B12.00B12.34B11.19B12.30B11.81B9.48B11.02B
Non-Current Liabilities
Non-Current Debt
25.18B25.18B25.18B25.20B22.95B22.96B22.96B21.21B23.19B23.19B21.53B21.54B21.44B24.90B22.15B22.14B22.14B22.13B20.86B23.83B
Convertible Debt
Non-Current Deffered Revenue
Preferred Stock Liabilities
Minority Interest
0.00B-0.01B-0.01B-0.02B-0.02B-0.03B-0.06B-0.06B-0.07B-0.08B-0.08B-0.08B-0.08B-0.08B-0.08B-0.08B-0.08B-0.08B-0.08B-0.08B
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
4.60B4.36B3.69B3.36B3.04B2.67B2.40B2.11B1.98B1.59B0.93B0.91B0.79B0.72B0.71B0.65B0.60B0.40B0.39B0.33B
Other Non-Current Liabilities
4.64B4.77B4.79B3.89B3.98B3.92B3.77B2.61B2.09B2.04B1.97B1.42B1.40B1.29B1.34B1.29B1.18B1.17B1.20B1.49B
Total Non-Current Liabilities
40.98B42.12B38.37B38.77B37.52B38.05B37.16B38.63B38.04B37.34B36.87B33.96B34.74B38.45B36.02B34.84B35.81B35.16B31.65B36.04B
Total Liabilities
45.63B46.89B43.16B42.66B41.50B41.96B40.94B41.24B40.13B39.38B38.84B35.38B36.13B39.75B37.36B36.13B36.99B36.32B32.85B37.53B
Shareholder's Equity
Total Debt
27.69B26.70B26.21B26.22B25.22B25.23B25.24B25.25B24.98B24.99B25.19B23.35B23.25B26.71B24.95B24.95B24.94B24.94B22.17B26.25B
Common Equity
21.47B21.06B19.91B20.21B21.06B21.21B20.94B21.09B22.24B22.75B17.45B18.20B18.39B19.25B19.08B19.59B21.54B22.70B23.43B11.83B
Liabilities and Shareholders Equity
67.10B67.95B63.08B62.87B62.56B63.17B61.88B62.34B62.37B62.12B56.29B53.58B54.52B58.99B56.43B55.72B58.53B59.02B56.28B49.36B
Retained Earnings
16.90B16.32B14.99B15.12B15.76B15.69B15.22B15.14B16.00B16.30B10.66B11.16B11.07B11.50B10.93B11.32B12.82B13.73B14.13B2.20B

Gilead Sciences Balance Sheet API

Pull Gilead Sciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GILD&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY